Primary Investigator:
Katherine Tuttle, M.D., Rodney Raabe, M.D. and Michael Ring, M.D.

Description:
This study is designed for individuals with hypertension and renal stenosis (narrowing of the arteries in the kidney). Participants are assigned to one of two treatment groups. Both groups receive optimal medical therapy for their renal disease, either with or without renal stenting. (Renal stenting is a medical procedure inserting a wire mesh tube into the artery to keep it open.)

Eligibility:

• History of systolic blood pressure over 155
• Currently taking 2 or more anti-hypertensive medications
• Diagnosed with renal artery stenosis of 80 to 99% or
• Diagnosed with renal artery stenosis of 60 to 80% with a 20 mm g gradient
• Other eligibility criteria may apply. Please contact study coordinator

Exclusions:

• Previous intervention to renal arteries.
• Acute illness such as MI (heart attack), stroke, TIA ( or transichemc attack) within 3 months of the study.
• Other exclusion criteria may apply. Please contact study coordinator

Study Timeline:
Closed to Enrollment

Study Contact:

Beth RN, CCRC  Beth.Aaron@providence.org
Ruthie, RN, CCRC Ruth.Franks@providence.org 

Study Sponsor:
National Institutes of Health: National Heart, Lung, and Blood Institute